Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy.

Jeon, Ye Won; Lim, Seung Taek; Gwak, HongKi; Park, Seon Young; Suh, Young Jin

Jeon, Ye Won; Lim, Seung Taek; Gwak, HongKi; Park, Seon Young; Suh, Young Jin.

Afiliação

Jeon YW; Department of Surgery, The Catholic University, St. Vincent's Hospital, Suwon, Korea.
Lim ST; Department of Surgery, The Catholic University, St. Vincent's Hospital, Suwon, Korea.
Gwak H; Department of Surgery, The Catholic University, St. Vincent's Hospital, Suwon, Korea.
Park SY; Department of Surgery, The Catholic University, St. Vincent's Hospital, Suwon, Korea.
Suh YJ; Department of Surgery, The Catholic University, St. Vincent's Hospital, Suwon, Korea.

J Breast Cancer ; 23(5): 521-532, 2020 10.

Article em En | MEDLINE | ID: mdl-33154827

Palavras-chave

Breast neoplasms; Drug therapy; Febrile neutropenia; Granulocyte colony-stimulating factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Breast Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google